Allele Biotech Pre-Announces its Product Line in iPSC Creation Using Baculoviral Vectors

As a new approach of establishing novel product lines and generating feedbacks and potential interests early on, Allele Biotech has started disclosing its intended/ongoing research plan on AlleleBlogs or through AlleleNews. This week, Allele Biotech has listed the main points that it intends to accomplish by developing a baculovirus-based iPS cell generating system to complement its existing lentiviral and retroviral vector systems for iPSCs. The plan was part of a grant proposal presented to the NIH during the stimulus grant rounds in mid-2009. There has also been interest on relevant service from Allele Biotech’s customers. The time for market launch is expected to be by the end of this year.

Allele Biotech R&D team welcomes any suggestions and discussions on the research plan and the resulting products. Comments can be made at the blog, through comments on this news, or directly to us through emails.